The effect of Lawsonia inermis (henna) vaginal cream on treatment of candida vaginitis

Phase 2

• Conditions: Candidal vulvovaginitis.; Candidiasis of vulva and vagina

• Registration Number: IRCT2016022119743N4
• Lead Sponsor: Vice chancellor for research, Ahvaz JundiShapur University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 75

Inclusion Criteria

sign and symptoms of vulvovaginal candidiasis; married women between 18-45 years old; patients who had a single sexual partner and they themselves were the only sexual partner of their respective spouse. Exclusion criteria: women who had used antibiotics, immunosuppressive drugs, or any vaginal drugs 14 days before the study; pregnancy; breast feeding; diabetes and immunodeficiency side effects of the drug.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Compelet remission. Timepoint: Seven and 14 days after treatment. Method of measurement: Evauation of clinical symptom's remission with questionnaire.

Secondary Outcome Measures

Name	Time	Method
Vaginal pH. Timepoint: Before intervention and 7 days after intervention. Method of measurement: By pH meter strips.;Vaginal culture results. Timepoint: Before intervention and 7 days after intervention. Method of measurement: Vaginal smear.